Monday, September 15, 2014

Gilead to license generic version of Sovaldi

FILE - This undated file photo provided by Gilead Sciences shows the hepatitis C medication Sovaldi. Gilead Sciences says it has reached a deal with several generic drugmakers to produce cheaper versions of its popular, expensive hepatitis C drug Sovaldi for use in developing countries. (AP Photo/Courtesy of Gilead Sciences, File) Gilead Sciences has reached a deal with several generic drugmakers to produce a cheaper version of its popular, $1,000-per-pill hepatitis C drug Sovaldi for use in developing countries.








via Health News Headlines - Yahoo News http://ift.tt/1DaEtIk
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)